ALLISON JOHNSON: Open Payments
NPI 1982466934 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 32 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $1,099
Food & beverage: $999Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $415 |
| Medtronic, Inc. | 1 | $134 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $125 |
| Tempus AI, Inc | 1 | $96 |
| Boston Scientific Corporation | 2 | $80 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| ABC Home Medical Supply, Inc. | 2 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| COLOPLAST CORP | 1 | $19 |
Products named: ERLEADA, INTERSTIM, PYLARIFY, RYBREVANT, XT CDX, General - Kidney Stone Disease, KEYTRUDA, YONSA.
Industry payments across MO — which companies pay providers there.
